EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Limited, each of which is a separate legal entity. Ernst & Young Limited is a Swiss company with registered seats in Switzerland providing services to clients in Switzerland.
Recent Searches
Learn about EY Biotech
At EY, we recognize the potential of your innovative ideas and the importance of expert guidance to bring them to life. In the rapidly evolving biotech industry, the path from concept to market leadership is complex and requires a strategic approach.
Our global network of biotech specialists is at the forefront of industry trends and challenges, offering professional services tailored to your business needs. We are committed to providing the strategic support necessary to navigate the biotech landscape and achieve sustainable growth.
EY Biotech - Multifaceted support from a single source
As an emerging biotech company, you are constantly facing new challenges such as looking for the next financing round, adapting to a shifting regulatory environment or meeting growing operational demands. Timely and reliable support at the right moment is paramount for commercial success. So why not partner from the outset with the best in every discipline that counts? We can help you avoid the common pitfalls, overcome unforeseen challenges, and identify unsuspected opportunities. EY offers you competent support specifically adapted to your current situation, so that you can stay ahead of the curve.
Our team of professionals specialized in the life sciences sector can offer your bespoke business support in all phases of your venture’s lifecycle. Partner with professionals who adapt to your current situation and anticipate the next step on your journey! Backed by our global network, we can offer you the multidisciplinary support you need, when you need it, wherever in the world you need it – all from a single source.
Our services at a glance
- Capital Agenda
- Cyber
- Audit
- Tax
- Regulatory & Quality
- Commercialization
- Environmental, Social & Governance
- Running the finance function (parts of, or in full), incl. ERP instance (e.g., SAP)
- IPO compliance and readiness assessment
- IFRS and/or US GAAP conversions
- Preparation of listing Prospectus
- Preparation of financial statements (non-audit clients)
- Advising on financial terms & accounting in connection with licensing, M&A, and carve-out transactions
- Accounting compliance and reporting support
- Financial restructuring support
- Scale-up strategy
- Valuation and due diligence services
- M&A and divestment services
- Business Modeling and reinvention
- Contract review and collaboration audits
- Outcomes-based pricing arrangements advisory services
- Digital Systems (ERP, DMS, etc.) selection and implementation
- Cyber Security
- Digital Service Management
- Data Privacy & Protection
- Data Platforms and Data Analytics
- AI and ML
- Ordinary and limited statutory examination audits
- Consolidated Financial Statements Audits around the globe
- Audit of IFRS / US GAAP conversions
- Audit services related to IPO’s (Comfort Letters / etc.)
- Audit of capital increases / decreases
- Audit services in relation to foundations
- Audit services in relation to EIC / Horizon 2020 grants
- IP structuring / licensing
- Tax structuring, restructuring
- Tax compliance
- R&D tax incentive
- Employee participations plans
- Licence requirements along supply chain
- Adaptation / localisation of Quality Management System
- Quality assessment for global / regional expansion
- Self-inspections
- Qualification of service providers
- Commercial and technical quality agreements
- Mock-up inspections for preparations
- Inspection support
- Communication with National Competent Authority
- Portfolio / franchise / brand strategy
- Launch & market access strategy
- Pricing & reimbursement strategy
- Payer mock negotiations
- Digital engagement strategy
- Omni-channel marketing
- Customer journey / clinical pathway
- Sustainable Financing & Incentives
- Decarbonization
- ESG Value Creation
- Compliance Risk & Reporting
- ESG Tech & Data Services
- Circular, Products, Supply Chain
- Environmental Impact Assessment
- Regulatory & ESG Standard Gap Assessment (EU Taxonomy, CSRD etc.)
Latest news
EY Firepower report: life sciences dealmaking – trends in 2026
Learn how life sciences organizations can accelerate dealmaking strategies to succeed.
During 2024, Switzerland’s biotech sector continued to demonstrate resilience despite significant financial and market challenges. Revenues remained strong at CHF 7.2 billion, while R&D investment grew to CHF 2.6 billion. Especially encouraging was the rise in private company investment which accounted for a record CHF 833 million of the total CHF 2.5 billion raised.
The Basel Area Life Sciences Ecosystem in a Global Landscape
What do life science companies need to thrive and how does the Basel Area life sciences ecosystem compare internationally? Read our study to find out.